Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 31.30
-0.10 (-0.32%)
Jul 24, 2026, 3:38 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 43 million as of July 24, 2026. Its market cap has increased by 245.86% in one year.
Market Cap
43.00M
Enterprise Value
41.70M
Revenue
20.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.30
ChartMarket Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 43.00M, a decrease of -62.21%. That is a compound annual growth rate of -11.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 43.00M | 213.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 86.83M |
| Spago Nanomedical AB | 76.74M |
| AcouSort AB | 75.13M |
| Ascelia Pharma AB | 67.97M |
| Pila Pharma AB | 57.79M |
| 2cureX AB | 57.43M |
| Modus Therapeutics Holding AB | 43.30M |
| Magle Chemoswed Holding AB | 33.29M |